<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Trigger control to enhance asthma management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Trigger control to enhance asthma management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Trigger control to enhance asthma management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rachel L Miller, MD, FAAAAI</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce S Bochner, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 14, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Asthma is a chronic lung disease characterized by airway obstruction, inflammation, and hyperresponsiveness [<a href="#rid1">1,2</a>]. A broad range of factors have been identified that can make asthma worse. These factors are often referred to as "asthma triggers." Trigger exposure may occur on a chronic or episodic basis. Identifying and avoiding asthma "triggers" are essential to preventing asthma flare-ups.</p><p>A description of factors that may contribute to asthma severity and suggestions for mitigation of these factors will be reviewed here. A general approach to asthma management is provided separately. (See  <a class="medical medical_review" href="/d/html/547.html" rel="external">"An overview of asthma management"</a>.)</p><p class="headingAnchor" id="H1799885289"><span class="h1">APPROACH TO THE PATIENT</span><span class="headingEndMark"> — </span>Asthma "triggers" are often thought of as airborne agents that can bring on an attack, but a variety of other exposures can cause or exacerbate symptoms, including the following categories of stimuli [<a href="#rid1">1,2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory infections (viruses, bacteria)</p><p class="bulletIndent1"><span class="glyph">●</span>Allergen exposure (inhalant, food, and occupational)</p><p class="bulletIndent1"><span class="glyph">●</span>Inhaled respiratory irritants (including tobacco and cannabis [marijuana] smoke and cold, dry air)</p><p class="bulletIndent1"><span class="glyph">●</span>Temperature and weather</p><p class="bulletIndent1"><span class="glyph">●</span>Physical activity</p><p class="bulletIndent1"><span class="glyph">●</span>Hormonal fluctuations</p><p class="bulletIndent1"><span class="glyph">●</span>Medications</p><p class="bulletIndent1"><span class="glyph">●</span>Emotional factors (eg, anxiety, stress)</p><p></p><p>Comorbidities, such as rhinitis, rhinovirus infection, gastroesophageal reflux, obesity, obstructive sleep apnea, depression, and anxiety, can trigger asthma symptoms as well [<a href="#rid2">2</a>].</p><p>The initial step toward managing asthma by reducing exposure to triggers is to assess patients for a range of factors that can make asthma worse  (<a class="graphic graphic_table graphicRef80507" href="/d/graphic/80507.html" rel="external">table 1</a>) [<a href="#rid1">1,2</a>]. Such assessment should take into account the intensity and duration of exposure, the patient's sensitivity to the agents encountered, and the clinical significance of the exposure/sensitivity in the context of the person's medical history [<a href="#rid1">1</a>]. Exposures at home, daycare, school, work, and regular leisure sites should be reviewed. Questions about work environment are particularly important as industrial or occupational exposures are responsible for 10 to 25 percent of cases of adult asthma [<a href="#rid3">3</a>].</p><p>After identification of potential asthma triggers in an individual, a plan can be devised with the patient or caregiver to enable them to reduce the exposure. Multicomponent interventions have yielded more evidence of success than single-component ones. For patients with predictable exposures to avoidable triggers, the following interventions may be useful [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete avoidance of the trigger (eg, mop or wet wipe instead of sweeping or dusting and consider dust mite proof encasings) as part of a multicomponent allergen mitigation intervention.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For individuals with asthma who are exposed to cockroaches or mice in the home and who have allergy symptoms or demonstrated sensitization to these allergens, integrated pest management, used alone or with other interventions, may reduce exposure to pest-related allergens in the home.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Limit exposure to the trigger if it cannot be completely avoided (eg, leave the room if someone starts smoking, move to another seat if someone with strong perfume sits near you, have someone else clean the house if you are allergic to indoor antigens).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Take an extra two puffs of a short-acting bronchodilator or an antihistamine prior to exposure to an unavoidable trigger. This approach should be implemented only if the first two options are not feasible. Patients should consult with their clinician to be sure before instituting this approach, and they should be careful not to exceed the amount of normally prescribed medication.</p><p></p><p>In addition to identifying asthma triggers, clinicians should be vigilant for comorbid conditions in patients with poorly controlled asthma, particularly when typical asthma triggers do not appear to be contributing. Conditions that can contribute to or mimic asthma symptoms include a broad spectrum of processes, such as rhinosinusitis, obesity, deconditioning, chronic obstructive pulmonary disease, allergic bronchopulmonary aspergillosis, paroxysmal vocal fold dysfunction, gastroesophageal reflux, sleep apnea, and mechanical restriction. These conditions are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5752.html" rel="external">"Evaluation of wheezing in infants and children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1455.html" rel="external">"Chronic obstructive pulmonary disease: Diagnosis and staging"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2419.html" rel="external">"Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/571.html" rel="external">"Gastroesophageal reflux and asthma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7533.html" rel="external">"An overview of rhinitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/523.html" rel="external">"Inducible laryngeal obstruction (paradoxical vocal fold motion)"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">RESPIRATORY INFECTIONS</span><span class="headingEndMark"> — </span>Respiratory infections are major contributors to asthma exacerbations, and a variety of respiratory infections have been implicated, including the common cold (particularly rhinovirus), influenza, respiratory syncytial virus, human metapneumovirus, sinus infections, and pneumonia [<a href="#rid4">4-7</a>]. However, the exact mechanism(s) by which infections trigger asthma exacerbations is unclear. Possibilities include airway inflammation with neutrophils [<a href="#rid8">8</a>] or eosinophils [<a href="#rid9">9</a>], alterations in airway receptors [<a href="#rid10">10,11</a>], and increased mucosal permeability to allergens [<a href="#rid12">12</a>]. Asthma flares that occur with a respiratory infection are frequently more severe than those caused by other triggers.</p><p>Several studies have noted clusters of asthma emergency department visits and hospitalizations occurring predictably after the return to school following summer vacation and other breaks [<a href="#rid13">13,14</a>]. Specifically, there was a "September asthma epidemic" approximately 18 days after Labor Day, with a lesser increase in attacks two days later in preschool children and six days later in adults [<a href="#rid13">13</a>]. Viral infections were the presumed cause, although allergen-induced inflammation (possibly exacerbated by the viral infection) may contribute [<a href="#rid15">15</a>]. In a study of urban children with uncontrolled allergic asthma, treatment with <a class="drug drug_general" data-topicid="10251" href="/d/drug information/10251.html" rel="external">omalizumab</a> reduced seasonal exacerbations in the fall and spring, possibly by improving interferon alpha-mediated antiviral defenses [<a href="#rid16">16,17</a>] and/or decreasing viral shedding and duration of infections, although the exact mechanism is not known [<a href="#rid18">18</a>].</p><p>Studies have been mixed regarding the role of atypical bacteria, such as <em>Mycoplasma pneumoniae</em> and <em>Chlamydia pneumoniae</em>, in causing asthma exacerbations and persistent asthma symptoms [<a href="#rid19">19,20</a>]. In a series of 31 children with persistent asthma, no relationship was found between detection of <em>M. pneumoniae</em> community-acquired respiratory distress syndrome toxin in respiratory secretions and worsening asthma [<a href="#rid21">21</a>].</p><p>For patients with poor asthma control, it is prudent to evaluate for possible contributions from chronic rhinosinusitis and allergic bronchopulmonary aspergillosis. (See  <a class="medical medical_review" href="/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7536.html" rel="external">"Relationships between rhinosinusitis and asthma"</a> and  <a class="medical medical_review" href="/d/html/2419.html" rel="external">"Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Mitigating the effects of viral infection</span><span class="headingEndMark"> — </span>For patients with asthma who have high-risk features (eg, required oral glucocorticoids in the past year or currently need hospitalization) and suspected or confirmed influenza infection, antiviral therapy may be indicated. The oral agent <a class="drug drug_general" data-topicid="9460" href="/d/drug information/9460.html" rel="external">oseltamivir</a> is preferred over the inhaled agent <a class="drug drug_general" data-topicid="10323" href="/d/drug information/10323.html" rel="external">zanamivir</a>, which has been associated with bronchoconstriction. The timing of treatment and choice of antiviral agents are discussed separately. (See  <a class="medical medical_review" href="/d/html/5985.html" rel="external">"Seasonal influenza in children: Management", section on 'Antiviral therapy'</a> and  <a class="medical medical_review" href="/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a>.)</p><p>There are no available antiviral therapies for rhinovirus infection, and symptomatic therapies to reduce nasal congestion, postnasal drip, fever, or cough have not been demonstrated to reduce the likelihood of asthma exacerbation.</p><p>For adults with increasing asthma symptoms in the setting of a presumed viral infection, quadrupling the dose of inhaled glucocorticoids is controversial and not established as helping in preventing the development of an asthma exacerbation [<a href="#rid7">7</a>]. The mechanism underlying protection of virus-induced asthma exacerbations by inhaled glucocorticoids is unclear, although some reports suggest that inhaled glucocorticoids are able to reduce airway eosinophils that develop after infections. (See  <a class="medical medical_review" href="/d/html/528.html" rel="external">"Acute exacerbations of asthma in adults: Home and office management", section on 'Quadrupling the dose of inhaled glucocorticoid'</a>.)</p><p>Data supporting the use of leukotriene antagonists in presumed virus-related asthma exacerbations are also mixed. (See  <a class="medical medical_review" href="/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management", section on 'Leukotriene receptor antagonists'</a>.)</p><p class="headingAnchor" id="H654195133"><span class="h2">Prevention</span><span class="headingEndMark"> — </span>The main strategies for prevention of respiratory viral infections are careful attention to hand hygiene  (<a class="graphic graphic_table graphicRef77676" href="/d/graphic/77676.html" rel="external">table 2</a>), avoidance of people with infections when possible, adequate amounts of sleep, and vaccination against seasonal influenza and pneumococcal infection. (See  <a class="medical medical_review" href="/d/html/16629.html" rel="external">"The common cold in children: Management and prevention", section on 'Prevention'</a> and  <a class="medical medical_review" href="/d/html/6868.html" rel="external">"The common cold in adults: Treatment and prevention", section on 'Prevention'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Flu vaccination</strong> – Influenza vaccination is recommended for children with asthma, children ages two through four years with recurrent wheezing, and adults with asthma. Vaccination with inactivated influenza virus does not increase the risk of an asthma exacerbation, and yearly vaccination is encouraged in order to reduce the risks of complications of influenza infection (ie, pneumonia) [<a href="#rid22">22,23</a>]. Live-attenuated influenza vaccine is <strong>not</strong> licensed for children or adults with asthma or children with a history of wheezing. (See  <a class="medical medical_review" href="/d/html/5960.html" rel="external">"Seasonal influenza in children: Prevention with vaccines"</a> and  <a class="medical medical_review" href="/d/html/7007.html" rel="external">"Seasonal influenza vaccination in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pneumococcal vaccination</strong> – Pneumonia complicates approximately up to 5 percent of pediatric asthma exacerbations [<a href="#rid24">24</a>], and the rate of invasive pneumococcal disease is greater among individuals with asthma [<a href="#rid25">25</a>]. Guidelines advise administering the 23-valent <a class="drug drug_general" data-topicid="9784" href="/d/drug information/9784.html" rel="external">pneumococcal polysaccharide vaccine</a> (PPSV23) to adults with asthma  (<a class="graphic graphic_table graphicRef86782" href="/d/graphic/86782.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/7021.html" rel="external">"Pneumococcal vaccination in adults"</a>.)</p><p></p><p class="bulletIndent1">Indications for vaccination of children with the <a class="drug drug_general" data-topicid="9906" href="/d/drug information/9906.html" rel="external">13-valent pneumococcal conjugate vaccine</a> (PCV13) or <a class="drug drug_general" data-topicid="131831" href="/d/drug information/131831.html" rel="external">20-valent pneumococcal conjugate vaccine</a> (PCV20) and <a class="drug drug_general" data-topicid="9784" href="/d/drug information/9784.html" rel="external">PPSV23</a> are discussed separately. (See  <a class="medical medical_review" href="/d/html/6053.html" rel="external">"Pneumococcal vaccination in children"</a>.)</p><p></p><p class="headingAnchor" id="H4"><span class="h1">ALLERGENS</span></p><p class="headingAnchor" id="H5"><span class="h2">Inhalant allergens</span><span class="headingEndMark"> — </span>Allergy is a primary cause of asthma symptoms [<a href="#rid1">1,2</a>]. Thus, the clinician must take a thorough history to determine if the patient has significant allergies. A questionnaire has been published to assist the clinician in assessing the relationship between allergen exposure and the presence of symptoms  (<a class="graphic graphic_table graphicRef80507" href="/d/graphic/80507.html" rel="external">table 1</a>).</p><p>Common inhalant allergens that can contribute to poor asthma control and cause exacerbations include [<a href="#rid26">26-29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Animal allergens (both pets and pests: cats, dogs, rodents)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>House dust mites (present in all but arid or high-altitude regions)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cockroaches</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Indoor and outdoor fungi (mold, mildew) [<a href="#rid30">30</a>] (see  <a class="medical medical_review" href="/d/html/15265.html" rel="external">"Building-related illness and building-related symptoms", section on 'Mold'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Outdoor pollen allergens (tree, grass, ragweed pollen)</p><p></p><p>If the patient suspects an allergic trigger, it is often helpful for them to keep a diary (recording exposures, activity/environment, ingestions, and peak expiratory flow readings) to see if there is a correlation between symptoms, lung function, and the suspected trigger.</p><p>Allergy testing (ie, skin testing or in vitro immunoglobulin E [IgE] immunoassays) can help confirm or exclude suspected triggers and should be performed in patients with persistent asthma, especially those who are exposed to perennial allergens [<a href="#rid31">31</a>]. It is important that the results are interpreted in the context of other diagnostic assessments, including medical history and physical examination, because a positive skin test or in vitro test (IgE immunoassay) result only means that the patient is sensitized to that allergen and has the potential to develop symptoms when exposed to that allergen. The diagnosis of allergy requires that the patient also has a history consistent with symptoms following exposure. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease"</a> and  <a class="medical medical_review" href="/d/html/5540.html" rel="external">"Overview of in vitro allergy tests"</a>.)</p><p>Measures for reducing exposure to indoor and outdoor allergens and guidelines for allergen immunotherapy are detailed separately. (See  <a class="medical medical_review" href="/d/html/530.html" rel="external">"Allergen avoidance in the treatment of asthma and allergic rhinitis"</a> and  <a class="medical medical_review" href="/d/html/361.html" rel="external">"Subcutaneous immunotherapy (SCIT) for allergic rhinoconjunctivitis and asthma: Indications and efficacy"</a> and  <a class="medical medical_review" href="/d/html/7538.html" rel="external">"Sublingual immunotherapy for allergic rhinitis and conjunctivitis: SLIT-tablets"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Food allergens</span><span class="headingEndMark"> — </span>Patients with food allergy may exhibit asthma symptoms as part of food-induced anaphylaxis, but food allergens <strong>rarely</strong> cause isolated asthma without other symptoms. Anaphylaxis should be suspected if a patient (especially a child or young adult) develops severe asthma symptoms soon after eating a food allergen in the absence of other apparent triggers. Patients with food allergy should avoid the culprit food and carry injectable <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>. (See  <a class="medical medical_review" href="/d/html/2398.html" rel="external">"Clinical manifestations of food allergy: An overview"</a> and  <a class="medical medical_review" href="/d/html/2406.html" rel="external">"Management of food allergy: Avoidance"</a>.)</p><p>Rarely, food allergens can be aerosolized in sufficient amounts that highly sensitized patients can develop asthmatic symptoms. As examples, patients sensitive to seafood, hen's egg, or cow's milk may react to steam, vapors, or sprays from the cooking or processing of these foods. A number of wheat flour-associated allergens can cause asthma symptoms via inhaled flour (baker's asthma). Asthmatic reactions to inhaled food allergens are reviewed separately. (See  <a class="medical medical_review" href="/d/html/2406.html" rel="external">"Management of food allergy: Avoidance", section on 'Skin contact and inhalation'</a> and  <a class="medical medical_review" href="/d/html/2412.html" rel="external">"Respiratory manifestations of food allergy"</a> and  <a class="medical medical_review" href="/d/html/95310.html" rel="external">"Grain allergy: Clinical features, diagnosis, and management"</a>.)</p><p>Sulfite sensitivity, although not an IgE-mediated food allergy, can present with isolated asthma symptoms triggered by the ingestion of foods that are treated with sulfites to prevent spoilage and discoloration. The foods include wine, vinegar, dried fruits, processed potato products, and others  (<a class="graphic graphic_table graphicRef66943" href="/d/graphic/66943.html" rel="external">table 4</a>). Up to 10 percent of adults with asthma may exhibit adverse reactions to the sulfites, which may include life-threatening reactions [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/2405.html" rel="external">"Allergic and asthmatic reactions to food additives", section on 'Sulfites and related compounds'</a>.)</p><p>Ingestion of alcoholic beverages may lead to asthma exacerbations in patients with aspirin-exacerbated respiratory disease (AERD) or systemic mastocytosis. (See  <a class="medical medical_review" href="/d/html/520.html" rel="external">"Aspirin-exacerbated respiratory disease", section on 'Reactions to alcoholic beverages'</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Occupational allergens</span><span class="headingEndMark"> — </span>Patients may develop asthma for the first time as a result of exposure to allergens in the workplace. This is referred to as occupational asthma and has been attributed to certain low-molecular-weight chemicals and high-molecular-weight organic materials  (<a class="graphic graphic_table graphicRef66185" href="/d/graphic/66185.html" rel="external">table 5</a>). Common culprits in occupational asthma include toluene diisocyanates, trimellitic anhydrides, enzymes, and wood dusts. Occupational asthma is distinct from "work-aggravated asthma," or preexisting asthma that worsens in the workplace setting. These disorders are reviewed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">IRRITANTS (INCLUDING CIGARETTE SMOKE)</span><span class="headingEndMark"> — </span>A variety of irritants can induce asthma symptoms, including cigarette smoke, cannabis smoke, fireplace smoke, ashes, aerosol sprays, perfumes, cooking odors, musty odors, shower steam, traffic fumes, air pollution, desert dust, and workplace irritants [<a href="#rid33">33-39</a>].</p><p class="headingAnchor" id="H952762504"><span class="h2">Cigarette smoke</span><span class="headingEndMark"> — </span>Cigarette smoke is a common airway irritant. Among patients with asthma, smokers have more severe symptoms, increased emergency department visits, increased rates of hospitalization, accelerated decline in lung function, and impaired responses to inhaled and systemic glucocorticoids than nonsmokers [<a href="#rid40">40-42</a>]. Children with environmental tobacco smoke exposure have a higher risk of developing asthma, more severe asthma symptoms, and more frequent exacerbations [<a href="#rid43">43-45</a>]. Smoking cessation is associated with improved lung function [<a href="#rid46">46</a>]. In addition, exposure to tobacco smoke exacerbates inflammatory airway responses to allergens [<a href="#rid47">47</a>].</p><p>Clinicians should advise patients with asthma to avoid personal and secondhand smoking [<a href="#rid1">1</a>]. Pediatricians should discuss smoking habits with parents and caregivers of pediatric patients. If a parent or caregiver is unwilling or unable to quit smoking, discuss not smoking in the same room in which children sleep or play. If feasible, instruct parents and caregivers to restrict their smoking to outside of the home. (See  <a class="medical medical_review" href="/d/html/16634.html" rel="external">"Overview of smoking cessation management in adults"</a>.)</p><p class="headingAnchor" id="H1868095078"><span class="h2">Cannabis smoke</span><span class="headingEndMark"> — </span>Cannabis (also called marijuana) smoke contains end products of pyrolysis similar to tobacco smoke, including polycyclic aromatic hydrocarbons and reactive oxygen species, and appears to alter airway immune function [<a href="#rid48">48</a>]. While cannabis has bronchodilator effects, which could be seen as beneficial in asthma, cannabis-induced bronchodilation can have the disadvantage of enabling greater penetration of smoke to smaller airways than cigarette smoke [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/7797.html" rel="external">"Cannabis use and disorder: Epidemiology, pharmacology, comorbidities, and adverse effects"</a>.)</p><p>The specific clinical effects of cannabis smoking in patients with asthma have not been fully studied, but frequent cannabis smoking (≥52 times/year) among young adults, after controlling for tobacco use, is associated with increased morning cough (odds ratio [OR] 3.46, 95% CI 2.02-5.93), sputum (OR 3.45, 95% CI 1.96-6.11), and wheeze (OR 1.95, 95% CI 1.11-3.42) [<a href="#rid50">50</a>]. In this study, quitting cannabis smoking was associated with a reduction in these symptoms to the level of nonusers. Based on these observations, patients with asthma should avoid exposure to cannabis smoke [<a href="#rid49">49</a>].</p><p>While the majority of respiratory effects of cannabis smoking are attributed to the irritant effects of the smoke, rare patients develop specific IgE-mediated allergy to Can s3, a lipid transfer protein. Sensitivity to Can s3 is associated with allergy symptoms to banana, tomato, and citrus but not via bet v1 sensitivity [<a href="#rid49">49</a>]. It may be that patients with IgE-mediated allergy to these food products should avoid all exposures (inhaled, oral) to cannabis. (See  <a class="medical medical_review" href="/d/html/2402.html" rel="external">"Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)"</a> and  <a class="medical medical_review" href="/d/html/2407.html" rel="external">"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)"</a>.)</p><p class="headingAnchor" id="H2482264132"><span class="h2">Indoor air pollution</span><span class="headingEndMark"> — </span>Fumes from unvented gas stoves have been associated with wheezing in children [<a href="#rid51">51</a>]. Changing to a nonpolluting, more effective indoor heat system is associated with an improved sense of well-being and reduced asthma symptoms in children, although not an improvement in lung function [<a href="#rid33">33</a>]. Wood burning stoves and fireplaces can also increase asthma symptoms.</p><p>Indoor exposures to volatile organic compounds (VOCs) and fragrances are thought to contribute to asthma, although supportive data are limited [<a href="#rid52">52-54</a>]. VOCs (eg, benzene, toluenes, xylenes, formaldehyde) are found in cleaning fluids, newly installed carpeting, paint, and furnishings in homes and offices [<a href="#rid34">34,55</a>]. Choosing unscented and nonaerosol products without VOC off-gassing and increasing air exchanges can minimize exposure to VOCs [<a href="#rid56">56</a>]. Chlorine bleach, while not a VOC, is an airway irritant.</p><p class="headingAnchor" id="H3165264132"><span class="h2">Outdoor air pollution</span><span class="headingEndMark"> — </span>Increases in ambient particulate matter (PM), elemental carbon/soot, nitrogen dioxide, and ozone have been associated with an increase in reports of wheeze, sales of short-acting bronchodilator medication, and hospitalizations for asthma [<a href="#rid57">57-59</a>]. Conversely, decreases in ambient air pollutants (nitrogen dioxide, ozone, and PM) in Southern California over 30 years of monitoring have been associated with decreases in chronic cough, chest congestion, and phlegm in children [<a href="#rid36">36</a>]. For a median reduction in nitrogen dioxide of 4.9 parts per billion (ppb), the OR for bronchitic symptoms among children with asthma at age 10 years was 0.79 (95% CI 0.67-0.94), with an absolute decrease in prevalence of 10 percent. For PM &lt;2.5 microns (PM<sub>2.5</sub>), the OR for a decrease in bronchitic symptoms was 0.68 (95% CI 0.53-0.86) for a median reduction in PM<sub>2.5</sub> of 6.8 mcg/m<sup>3</sup>, and the absolute decrease in prevalence was 15.4 percent.</p><p class="headingAnchor" id="H357323690"><span class="h2">Wildfire smoke</span><span class="headingEndMark"> — </span>Wildfires result in short- to medium-term exposure to high levels of particulate matter and elemental carbon/soot, which may exacerbate asthma symptoms. Climate change and land-use change are worsening the risk of wildfires, with anticipated increases in number and extent of extreme fires in coming decades [<a href="#rid60">60</a>]. In one report analyzing the impact of the 2023 Canadian wildfire smoke on residents of New York City, the number of emergency department visits for asthma symptoms during the three-day period of peak smoke exposure was 44 percent higher (261 versus 182 per day; incidence rate ratio 1.44, 95% CI 1.3-1.6) than during unexposed reference periods [<a href="#rid61">61</a>]. This period of smoke exposure coincided with an over 10-fold increase in PM<sub>2.5 </sub>levels (101 versus 9 mcg/m<sup>3</sup>) in the New York City area. A much longer burning, severe fire similarly worsened air quality in Eastern Australia for 19 weeks in 2019 to 2020, with 55 days of high PM<sub>2.5 </sub>(mean exposure 32 mcg/m<sup>3</sup>) during this period [<a href="#rid62">62</a>]. Survey data of patients with severe asthma indicate that over 80 percent suffered worsening symptoms over this timeframe [<a href="#rid63">63</a>], with particularly worsened symptoms in those with predisposition to cough and throat irritation (laryngeal hypersensitivity) [<a href="#rid64">64</a>]. Additional information on the larger health impacts of wildfire smoke and management of wildfire health risks are discussed separately. (See  <a class="medical medical_review" href="/d/html/140586.html" rel="external">"Climate emergencies", section on 'Wildfires'</a>.)</p><p class="headingAnchor" id="H1718314585"><span class="h2">Desert dust and coastal red tide</span><span class="headingEndMark"> — </span>Days with high concentrations of desert dust are associated with an increase in asthma hospitalizations [<a href="#rid35">35</a>]. Desert dust contains quartz particles (crystalline silica), which have been associated with respiratory disease in occupationally exposed persons. Dust particles originating from desert dust storms in one location can be transported across the atmosphere to affect wide regions of the globe.</p><p>Red tide blooms due to the marine dinoflagellate, <em>Karenia brevis</em>, occur along the Gulf of Mexico and are associated with aerosolization of brevetoxin produced by the organism [<a href="#rid65">65,66</a>]. Observational studies suggest that inhalational exposure can lead to increases in asthma symptoms and decreases in lung function [<a href="#rid65">65,67</a>].</p><p class="headingAnchor" id="H743379063"><span class="h2">Workplace irritants</span><span class="headingEndMark"> — </span>Workplace irritants, such as glacial acetic acid, cleaning products, and chlorine, are commonly used by factory workers and professional cleaners. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">ATMOSPHERIC CONDITIONS</span></p><p class="headingAnchor" id="H2280978538"><span class="h2">Temperature and humidity</span><span class="headingEndMark"> — </span>Extremes of temperature and humidity can cause bronchoconstriction and increase asthma symptoms during physical activity. Other weather conditions, such as thunderstorms, cause asthma exacerbations in some patients.</p><p class="bulletIndent1"><span class="glyph">●</span>Temperature and humidity can influence the severity of exercise-induced asthma [<a href="#rid68">68</a>]. While the precise mechanism is not clear, the inhalation of cold and dry air appears to increase bronchoconstriction during or shortly after exercise. One theory suggests that increased breathing during exercise causes water loss in the airways. This water loss leads to an exchange of molecules in the cells lining the airways, causing inflammation that ultimately leads to bronchoconstriction [<a href="#rid69">69</a>].</p><p></p><p class="bulletIndent1">A second theory suggests increased breathing during exercise leads to cooling of the airways. This cooling is followed by the rapid flow of blood into airway blood vessels and resultant edema [<a href="#rid69">69,70</a>]. (See  <a class="medical medical_review" href="/d/html/533.html" rel="external">"Exercise-induced bronchoconstriction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hot, humid air can sometimes cause bronchoconstriction, as demonstrated in animal studies and a small study of humans [<a href="#rid71">71</a>]. The response to hot, humid air is blunted by pretreatment with inhaled <a class="drug drug_general" data-topicid="8570" href="/d/drug information/8570.html" rel="external">ipratropium</a>, suggesting that the bronchoconstriction is mediated by vagal bronchopulmonary C-fiber sensory nerves.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Conditions related to climate change are predicted to increase exposure to asthma triggers. They may include more hot, sunny days that increase ozone-related asthma symptoms, rises in sea level or altered rainfall that may affect the dampness of indoor environments leading to more dust mite and mold growth, and higher ambient carbon dioxide levels that may increase exposure to allergens by lengthening the pollen season [<a href="#rid72">72,73</a>].</p><p></p><p class="headingAnchor" id="H486751745"><span class="h2">Thunderstorms</span><span class="headingEndMark"> — </span>Asthma exacerbations that occur in the hours following a thunderstorm are known as "thunderstorm asthma." Epidemics of thunderstorm asthma generally occur during pollen seasons and occur worldwide, with nearly half reported in Australia [<a href="#rid74">74-76</a>]. In the 30 hours after a thunderstorm in Melbourne in 2016, 3400 excess visits to emergency departments for respiratory symptoms were reported across the city [<a href="#rid77">77</a>]. Studies of weather events have found increased levels of allergens present in the air, particularly pollen and mold spores, and most patients with thunderstorm asthma have pollen-induced seasonal allergic rhinitis [<a href="#rid78">78,79</a>]. Wet conditions at the beginning of a thunderstorm can cause pollen grains to rupture, increasing the concentration of pollen debris [<a href="#rid80">80</a>]. This debris can be inhaled into the lower airways, triggering an asthma exacerbation [<a href="#rid81">81</a>]. Elevated ozone levels may also play a role [<a href="#rid82">82</a>], but this has not been replicated [<a href="#rid76">76</a>]. In a multicenter study of adults from Melbourne with a past diagnosis of thunderstorm asthma and/or seasonal allergic rhinitis, risk factors for thunderstorm asthma were reported to include higher rye grass specific IgE levels, eosinophil counts, and fractional exhaled nitric oxide levels, and, if associated with presentation to a hospital, lower lung function and higher scores on the Asthma Control Questionnaire [<a href="#rid79">79</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Potential interventions</span></p><p class="bulletIndent1"><span class="glyph">●</span>Simply being aware of these triggers can help patients prepare for different environments and anticipate problems to gain a better sense of control over their asthma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Masks and scarves that trap heat and moisture when a person breathes out and warm cold air during inhalation may help persons with asthma who work, exercise, or spend time in cold temperatures [<a href="#rid83">83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of a short-acting beta-agonist (SABA; such as <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>) prior to exercise in cold or dry conditions or at the onset of storms during pollen seasons can help prevent symptom flares.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients whose asthma is triggered by pollen or mold allergy should be made aware that the conditions at the beginning of a thunderstorm during pollen season can be particularly troublesome and advised to avoid being outdoors during thunderstorms.</p><p></p><p class="headingAnchor" id="H13"><span class="h1">PHYSICAL ACTIVITY</span><span class="headingEndMark"> — </span>Exercise-induced bronchoconstriction (EIB) affects 80 to 90 percent of people with symptomatic asthma. However, aerobic exercise has substantial health benefits and may lessen sensitivity to asthma triggers [<a href="#rid84">84-86</a>]. Thus, exercise should be encouraged, <strong>not</strong> avoided. The evaluation and management of EIB are discussed separately. (See  <a class="medical medical_review" href="/d/html/533.html" rel="external">"Exercise-induced bronchoconstriction"</a>.)</p><p>Certain interventions can help reduce asthma symptoms during exercise and can be tailored to the clinical setting  (<a class="graphic graphic_table graphicRef105874" href="/d/graphic/105874.html" rel="external">table 6</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Ensure that asthma is well controlled. Exercise-related symptoms are more likely to occur when asthma is poorly controlled. (See  <a class="medical medical_review" href="/d/html/547.html" rel="external">"An overview of asthma management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anticipate problems related to temperature and humidity of inspired air (eg, cold, dry air, or high humidity).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Build-up the patient's activity level gradually as better cardiovascular fitness reduces the minute ventilation required for a given level of exercise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The role of a preexercise warm-up is unclear and should be based on the individual patient's experience.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Keep a short-acting beta-agonist (SABA; such as <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>) on hand to treat asthma symptoms. Some people may use a SABA 5 to 15 minutes prior to exercise to prevent symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional pharmacologic options for the management of exercise-triggered asthma are discussed separately. (See  <a class="medical medical_review" href="/d/html/533.html" rel="external">"Exercise-induced bronchoconstriction", section on 'Management'</a> and  <a class="medical medical_review" href="/d/html/558.html" rel="external">"Beta agonists in asthma: Acute administration and prophylactic use", section on 'Use in exercise-induced asthma'</a> and  <a class="medical medical_review" href="/d/html/553.html" rel="external">"Antileukotriene agents in the management of asthma"</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">HORMONAL FLUCTUATIONS</span><span class="headingEndMark"> — </span>Hormonal fluctuations associated with the menstrual cycle and with pregnancy can affect the frequency and severity of asthma symptoms in some patients.</p><p class="headingAnchor" id="H3150082"><span class="h2">Perimenstrual asthma</span><span class="headingEndMark"> — </span>Worsening of asthma symptoms prior to or during menstruation, known as perimenstrual asthma, has been reported in up to 30 percent of females with asthma [<a href="#rid87">87,88</a>], although other studies have not been able to clearly replicate this syndrome [<a href="#rid89">89</a>]. The pathophysiology responsible for this phenomenon is unclear, although changes in estradiol, progesterone, and testosterone levels have been associated with changes in markers of atopy and asthma (eg, fractional exhaled nitric oxide and skin test diameters), upregulation of eosinophils and mast cells, and increased bronchial reactivity [<a href="#rid88">88,90-92</a>]. Females with hormonally associated asthma tend to have more severe disease than females whose asthma is unaffected by hormone levels, and near-fatal events have been reported in association with perimenstrual asthma patients [<a href="#rid93">93</a>].</p><p>As females may take nonsteroidal antiinflammatory drugs (NSAIDs) to control premenstrual syndrome and dysmenorrhea, it is important to determine that a perimenstrual flare in asthma symptoms is not caused by ingestion of an NSAID by a patient with aspirin-exacerbated asthma. <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a> sensitivity may be more prevalent in females with perimenstrual asthma [<a href="#rid87">87</a>]. (See  <a class="medical medical_review" href="/d/html/520.html" rel="external">"Aspirin-exacerbated respiratory disease"</a>.)</p><p>The optimal pharmacologic management of perimenstrual flares of asthma has not been determined [<a href="#rid90">90</a>]. Asthma medications may need perimenstrual adjustment to prevent asthma flares.</p><p>Leukotriene-receptor antagonists appeared protective against perimenstrual worsening of asthma in one small series [<a href="#rid94">94</a>].</p><p class="headingAnchor" id="H3150119"><span class="h2">Pregnancy</span><span class="headingEndMark"> — </span>Pregnancy can aggravate asthma in approximately one-third of patients, while one-third experience no change, and one-third experience symptomatic improvement. Thus, asthma should be monitored closely during pregnancy. (See  <a class="medical medical_review" href="/d/html/555.html" rel="external">"Asthma in pregnancy: Clinical course and physiologic changes"</a> and  <a class="medical medical_review" href="/d/html/554.html" rel="external">"Management of asthma during pregnancy"</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">MEDICATIONS</span><span class="headingEndMark"> — </span>Certain medications can aggravate asthma, including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Beta blockers</strong> – Nonselective beta blockers can cause airflow limitation and reduce the bronchodilating effect of inhaled beta agonists and are generally avoided in patients with asthma. Selective beta-1 blockers cause a decrease in forced expiratory volume in one second (FEV<sub>1</sub>) of 7 percent on average but ≥20 percent in some patients. The effects of beta-blocking agents are reviewed separately. (See  <a class="medical medical_review" href="/d/html/3831.html" rel="external">"Treatment of hypertension in asthma and COPD"</a>.)</p><p></p><p class="bulletIndent1">In addition, topical beta blocker eye drops, especially nonselective ones (eg, <a class="drug drug_general" data-topicid="9997" href="/d/drug information/9997.html" rel="external">timolol</a>) [<a href="#rid95">95</a>] but also cardioselective ones (eg, <a class="drug drug_general" data-topicid="9145" href="/d/drug information/9145.html" rel="external">betaxolol</a>) [<a href="#rid96">96</a>], have been reported to reduce lung function and induce asthma hospitalizations, presumably through its systemic absorption [<a href="#rid97">97</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aspirin</strong><strong> and NSAIDs</strong> – <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a> and other nonsteroidal antiinflammatory drugs (NSAIDs) can cause acute severe exacerbation of asthma in patients with aspirin-exacerbated respiratory disease (AERD). Patients with AERD should avoid aspirin and all NSAIDs that inhibit cyclooxygenase 1, unless they have been desensitized to aspirin  (<a class="graphic graphic_table graphicRef62880" href="/d/graphic/62880.html" rel="external">table 7</a>). Caution is advised when prescribing aspirin or other NSAIDs to patients with asthma and nasal polyposis. (See  <a class="medical medical_review" href="/d/html/520.html" rel="external">"Aspirin-exacerbated respiratory disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ACE inhibitors</strong> – Angiotensin-converting enzyme (ACE) inhibitors can cause cough, which could be mistaken for increased asthma symptoms, and rarely have been associated with worsening asthma control. (See  <a class="medical medical_review" href="/d/html/3816.html" rel="external">"Major side effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers", section on 'Cough'</a> and  <a class="medical medical_review" href="/d/html/3831.html" rel="external">"Treatment of hypertension in asthma and COPD", section on 'ACE inhibitors'</a>.)</p><p></p><p>For many years, it was believed that excessive drying of bronchial secretions by first-generation antihistamines (due to their anticholinergic properties) would adversely affect asthma. However, this effect was never demonstrated to be clinically significant. Newer, nonsedating antihistamines have less of an anticholinergic effect and appear beneficial in the treatment of asthma [<a href="#rid98">98</a>].</p><p>Careful review of the medication list is appropriate for asthma patients presenting with increased asthma symptoms.</p><p class="headingAnchor" id="H19"><span class="h1">EMOTIONAL FACTORS</span><span class="headingEndMark"> — </span>Anxiety, depression, chronic stress, and stressors, such as exposure to community violence, are associated with greater rates of asthma exacerbations in patients with asthma [<a href="#rid99">99-101</a>]. Parental/caregiver depression and perceived stress are associated with wheeze and more severe asthma in children [<a href="#rid102">102,103</a>].</p><p>Counseling (eg, cognitive behavioral therapy) and sometimes medications can help alleviate depression and anxiety [<a href="#rid101">101,104</a>]. Some patients may need help distinguishing between asthma flares and panic attacks. Psychologists and family counselors can assist patients and parents/caregivers of children with asthma with stress management and provide advice if asthma disrupts a patient's or family's personal life. (See  <a class="medical medical_review" href="/d/html/14632.html" rel="external">"Generalized anxiety disorder in adults: Cognitive-behavioral therapy and other psychotherapies"</a> and  <a class="medical medical_review" href="/d/html/108804.html" rel="external">"Management of panic disorder with or without agoraphobia in adults"</a> and  <a class="medical medical_review" href="/d/html/15927.html" rel="external">"Psychotherapy for anxiety disorders in children and adolescents"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/16111.html" rel="external">"Patient education: Avoiding asthma triggers (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/15344.html" rel="external">"Patient education: Asthma in children (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/15343.html" rel="external">"Patient education: Asthma in adults (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/86148.html" rel="external">"Patient education: Secondhand smoke and children (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/112887.html" rel="external">"Patient education: Exercise-induced asthma (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/373.html" rel="external">"Patient education: Trigger avoidance in asthma (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/366.html" rel="external">"Patient education: How to use a peak flow meter (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/1222.html" rel="external">"Patient education: Asthma symptoms and diagnosis in children (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/376.html" rel="external">"Patient education: Exercise-induced asthma (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common triggers for asthma </strong>– Common triggers for asthma exacerbations include respiratory tract infections, airborne allergens (for patients with allergic asthma), inhaled irritants (eg, tobacco smoke), extremes of temperature and humidity (eg, very cold, dry air), and physical exercise  (<a class="graphic graphic_table graphicRef80507" href="/d/graphic/80507.html" rel="external">table 1</a>). (See <a class="local">'Respiratory infections'</a> above and <a class="local">'Allergens'</a> above and <a class="local">'Irritants (including cigarette smoke)'</a> above and <a class="local">'Atmospheric conditions'</a> above and <a class="local">'Physical activity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Food allergens <strong>rarely</strong> cause isolated asthma without other symptoms. However, patients with food allergy may exhibit asthma symptoms as part of food-induced anaphylaxis, and inhaled food allergens can occasionally provoke asthma symptoms. (See <a class="local">'Food allergens'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A variety of irritants can induce asthma symptoms, including cigarette and cannabis smoke, fireplace smoke, ashes, aerosol sprays, perfumes, cooking odors, musty odors, shower steam, traffic fumes, air pollution, desert dust, and workplace irritants (eg, glacial acetic acid, cleaning products, chlorine). (See <a class="local">'Irritants (including cigarette smoke)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Extremes of temperature and humidity can cause bronchoconstriction and increase asthma symptoms during physical activity. Other weather conditions, such as thunderstorms, cause asthma exacerbations in some patients. (See <a class="local">'Atmospheric conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exercise should be encouraged </strong>– While exercise-induced bronchoconstriction (EIB) affects 80 to 90 percent of people with symptomatic asthma, aerobic exercise has substantial health benefits and may lessen sensitivity to asthma triggers. Thus, exercise should be encouraged, <strong>not</strong> avoided. Certain interventions can reduce asthma symptoms during exercise  (<a class="graphic graphic_table graphicRef105874" href="/d/graphic/105874.html" rel="external">table 6</a>). (See <a class="local">'Physical activity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Relationship to menstruation </strong>– Worsening of asthma symptoms prior to or during menstruation, known as perimenstrual asthma, has been reported in up to 30 percent of females with asthma. Pregnancy can aggravate asthma in approximately one-third of females, while one-third experience no change, and one-third experience symptomatic improvement. (See <a class="local">'Hormonal fluctuations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications </strong>– Medications, such as beta blockers (particularly nonselective beta blockers), <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> and nonsteroidal antiinflammatory drugs (NSAIDs), and angiotensin-converting enzyme (ACE) inhibitors can cause asthma flares in some individuals, although ACE inhibitors more typically cause a cough without asthma. (See <a class="local">'Medications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mental health and external stressors </strong>– Anxiety, depression, and chronic stress, such as exposure to community violence, are associated with greater rates of asthma exacerbations in patients with asthma. Parental/caregiver depression and stress are associated with more severe asthma in children. Interventions, such as cognitive behavioral therapy, counselling about stress management, and sometimes medication, can help ameliorate these triggers. (See <a class="local">'Emotional factors'</a> above.)</p><p></p><p class="headingAnchor" id="H3335625558"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges William Bailey, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020; 146:1217.</a></li><li class="breakAll">2023 Global Initiative for Asthma (GINA) Report: Global Strategy for Asthma Management and Prevention. www.ginasthma.org/2023-gina-main-report (Accessed on May 15, 2023).</li><li><a class="nounderline abstract_t">Maestrelli P, Henneberger PK, Tarlo S, et al. Causes and Phenotypes of Work-Related Asthma. Int J Environ Res Public Health 2020; 17.</a></li><li><a class="nounderline abstract_t">Rudd PA, Thomas BJ, Zaid A, et al. Role of human metapneumovirus and respiratory syncytial virus in asthma exacerbations: where are we now? Clin Sci (Lond) 2017; 131:1713.</a></li><li><a class="nounderline abstract_t">Lambert KA, Prendergast LA, Dharmage SC, et al. The role of human rhinovirus (HRV) species on asthma exacerbation severity in children and adolescents. J Asthma 2018; 55:596.</a></li><li><a class="nounderline abstract_t">Steinke JW, Borish L. Immune Responses in Rhinovirus-Induced Asthma Exacerbations. Curr Allergy Asthma Rep 2016; 16:78.</a></li><li><a class="nounderline abstract_t">Castillo JR, Peters SP, Busse WW. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J Allergy Clin Immunol Pract 2017; 5:918.</a></li><li><a class="nounderline abstract_t">Crisford H, Sapey E, Rogers GB, et al. Neutrophils in asthma: the good, the bad and the bacteria. Thorax 2021; 76:835.</a></li><li><a class="nounderline abstract_t">Kim JH, Cho TS, Moon JH, et al. Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia. Allergy Asthma Immunol Res 2014; 6:428.</a></li><li><a class="nounderline abstract_t">Harford TJ, Rezaee F, Scheraga RG, et al. Asthma predisposition and respiratory syncytial virus infection modulate transient receptor potential vanilloid 1 function in children's airways. J Allergy Clin Immunol 2018; 141:414.</a></li><li><a class="nounderline abstract_t">Omar S, Clarke R, Abdullah H, et al. Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells. PLoS One 2017; 12:e0171681.</a></li><li><a class="nounderline abstract_t">Gangl K, Waltl EE, Vetr H, et al. Infection with Rhinovirus Facilitates Allergen Penetration Across a Respiratory Epithelial Cell Layer. Int Arch Allergy Immunol 2015; 166:291.</a></li><li><a class="nounderline abstract_t">Johnston NW, Johnston SL, Norman GR, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol 2006; 117:557.</a></li><li><a class="nounderline abstract_t">Eggo RM, Scott JG, Galvani AP, Meyers LA. Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model. Proc Natl Acad Sci U S A 2016; 113:2194.</a></li><li><a class="nounderline abstract_t">Hoch HE, Calatroni A, West JB, et al. Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index. J Allergy Clin Immunol 2017; 140:1130.</a></li><li><a class="nounderline abstract_t">Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364:1005.</a></li><li><a class="nounderline abstract_t">Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol 2015; 136:1476.</a></li><li><a class="nounderline abstract_t">Esquivel A, Busse WW, Calatroni A, et al. Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma. Am J Respir Crit Care Med 2017; 196:985.</a></li><li><a class="nounderline abstract_t">Yeh JJ, Wang YC, Hsu WH, Kao CH. Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study. J Allergy Clin Immunol 2016; 137:1017.</a></li><li><a class="nounderline abstract_t">Kassisse E, García H, Prada L, et al. Prevalence of Mycoplasma pneumoniae infection in pediatric patients with acute asthma exacerbation. Arch Argent Pediatr 2018; 116:179.</a></li><li><a class="nounderline abstract_t">Wood PR, Kampschmidt JC, Dube PH, et al. Mycoplasma pneumoniae and health outcomes in children with asthma. Ann Allergy Asthma Immunol 2017; 119:146.</a></li><li><a class="nounderline abstract_t">The American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345:1529.</a></li><li><a class="nounderline abstract_t">Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2013; :CD000364.</a></li><li><a class="nounderline abstract_t">Florin TA, Carron H, Huang G, et al. Pneumonia in Children Presenting to the Emergency Department With an Asthma Exacerbation. JAMA Pediatr 2016; 170:803.</a></li><li><a class="nounderline abstract_t">Weycker D, Farkouh RA, Strutton DR, et al. Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BMC Health Serv Res 2016; 16:182.</a></li><li><a class="nounderline abstract_t">Blatter J, Forno E, Brehm J, et al. Fungal exposure, atopy, and asthma exacerbations in Puerto Rican children. Ann Am Thorac Soc 2014; 11:925.</a></li><li><a class="nounderline abstract_t">Sharpe RA, Bearman N, Thornton CR, et al. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. J Allergy Clin Immunol 2015; 135:110.</a></li><li><a class="nounderline abstract_t">Gold DR, Adamkiewicz G, Arshad SH, et al. NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and management. J Allergy Clin Immunol 2017; 140:933.</a></li><li><a class="nounderline abstract_t">Annesi-Maesano I, Cecchi L, Biagioni B, et al. Is exposure to pollen a risk factor for moderate and severe asthma exacerbations? Allergy 2023; 78:2121.</a></li><li><a class="nounderline abstract_t">Soffer N, Green BJ, Acosta L, et al. Alternaria is associated with asthma symptoms and exhaled NO among NYC children. J Allergy Clin Immunol 2018; 142:1366.</a></li><li><a class="nounderline abstract_t">Eggleston PA, Bush RK, American Academy of Asthma, Allergy and Immunology. Environmental allergen avoidance: an overview. J Allergy Clin Immunol 2001; 107:S403.</a></li><li><a class="nounderline abstract_t">Vally H, Misso NL. Adverse reactions to the sulphite additives. Gastroenterol Hepatol Bed Bench 2012; 5:16.</a></li><li><a class="nounderline abstract_t">Howden-Chapman P, Pierse N, Nicholls S, et al. Effects of improved home heating on asthma in community dwelling children: randomised controlled trial. BMJ 2008; 337:a1411.</a></li><li><a class="nounderline abstract_t">Rumchev K, Spickett J, Bulsara M, et al. Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax 2004; 59:746.</a></li><li><a class="nounderline abstract_t">Kanatani KT, Ito I, Al-Delaimy WK, et al. Desert dust exposure is associated with increased risk of asthma hospitalization in children. Am J Respir Crit Care Med 2010; 182:1475.</a></li><li><a class="nounderline abstract_t">Berhane K, Chang CC, McConnell R, et al. Association of Changes in Air Quality With Bronchitic Symptoms in Children in California, 1993-2012. JAMA 2016; 315:1491.</a></li><li><a class="nounderline abstract_t">Chatkin JM, Dullius CR. The management of asthmatic smokers. Asthma Res Pract 2016; 2:10.</a></li><li><a class="nounderline abstract_t">Rosenquist NA, Metcalf WJ, Ryu SY, et al. Acute associations between PM2.5 and ozone concentrations and asthma exacerbations among patients with and without allergic comorbidities. J Expo Sci Environ Epidemiol 2020; 30:795.</a></li><li><a class="nounderline abstract_t">Altman MC, Kattan M, O'Connor GT, et al. Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis. Lancet Planet Health 2023; 7:e33.</a></li><li><a class="nounderline abstract_t">Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60:282.</a></li><li><a class="nounderline abstract_t">Silverman RA, Hasegawa K, Egan DJ, et al. Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011-2012. Respir Med 2017; 125:89.</a></li><li><a class="nounderline abstract_t">Tiotiu A, Ioan I, Wirth N, et al. The Impact of Tobacco Smoking on Adult Asthma Outcomes. Int J Environ Res Public Health 2021; 18.</a></li><li><a class="nounderline abstract_t">Akinbami LJ, Kit BK, Simon AE. Impact of environmental tobacco smoke on children with asthma, United States, 2003-2010. Acad Pediatr 2013; 13:508.</a></li><li class="breakAll">US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Public Health Service; Rockville, MD 2006.</li><li class="breakAll">Quinto KB, Kit BK, Lukacs SL, Akinbami L. Environmental tobacco smoke exposure in children aged 3-19 years with and without asthma in the United States, 1999-2010. NCHS data brief, no 126, National Center for Health Statistics; Hyattsville, MD 2013.</li><li><a class="nounderline abstract_t">Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174:127.</a></li><li><a class="nounderline abstract_t">Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review. Int J Environ Res Public Health 2018; 15.</a></li><li><a class="nounderline abstract_t">Preteroti M, Wilson ET, Eidelman DH, Baglole CJ. Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease. Respir Res 2023; 24:95.</a></li><li><a class="nounderline abstract_t">Rabinovitch N, Leung DYM, Covar R. The highs and lows of marijuana use in allergy. Ann Allergy Asthma Immunol 2018; 121:14.</a></li><li><a class="nounderline abstract_t">Hancox RJ, Shin HH, Gray AR, et al. Effects of quitting cannabis on respiratory symptoms. Eur Respir J 2015; 46:80.</a></li><li><a class="nounderline abstract_t">Pilotto LS, Nitschke M, Smith BJ, et al. Randomized controlled trial of unflued gas heater replacement on respiratory health of asthmatic schoolchildren. Int J Epidemiol 2004; 33:208.</a></li><li><a class="nounderline abstract_t">Nurmatov UB, Tagiyeva N, Semple S, et al. Volatile organic compounds and risk of asthma and allergy: a systematic review. Eur Respir Rev 2015; 24:92.</a></li><li><a class="nounderline abstract_t">Quirós-Alcalá L, Wilson S, Witherspoon N, et al. Volatile organic compounds and particulate matter in child care facilities in the District of Columbia: Results from a pilot study. Environ Res 2016; 146:116.</a></li><li><a class="nounderline abstract_t">van Vliet D, Smolinska A, Jöbsis Q, et al. Can exhaled volatile organic compounds predict asthma exacerbations in children? J Breath Res 2017; 11:016016.</a></li><li><a class="nounderline abstract_t">Jaakkola JJ, Parise H, Kislitsin V, et al. Asthma, wheezing, and allergies in Russian schoolchildren in relation to new surface materials in the home. Am J Public Health 2004; 94:560.</a></li><li><a class="nounderline abstract_t">Chin JY, Godwin C, Parker E, et al. Levels and sources of volatile organic compounds in homes of children with asthma. Indoor Air 2014; 24:403.</a></li><li><a class="nounderline abstract_t">Commodore S, Ferguson PL, Neelon B, et al. Reported Neighborhood Traffic and the Odds of Asthma/Asthma-Like Symptoms: A Cross-Sectional Analysis of a Multi-Racial Cohort of Children. Int J Environ Res Public Health 2020; 18.</a></li><li><a class="nounderline abstract_t">Orellano P, Quaranta N, Reynoso J, et al. Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis. PLoS One 2017; 12:e0174050.</a></li><li><a class="nounderline abstract_t">Tiotiu AI, Novakova P, Nedeva D, et al. Impact of Air Pollution on Asthma Outcomes. Int J Environ Res Public Health 2020; 17.</a></li><li class="breakAll">2022 UN Environmental Programme report: www.unep.org/resources/report/spreading-wildfire-rising-threat-extraordinary-landscape-fires (Accessed on November 05, 2023).</li><li><a class="nounderline abstract_t">Chen K, Ma Y, Bell ML, Yang W. Canadian Wildfire Smoke and Asthma Syndrome Emergency Department Visits in New York City. JAMA 2023; 330:1385.</a></li><li><a class="nounderline abstract_t">Borchers Arriagada N, Palmer AJ, Bowman DM, et al. Unprecedented smoke-related health burden associated with the 2019-20 bushfires in eastern Australia. Med J Aust 2020; 213:282.</a></li><li><a class="nounderline abstract_t">Mason KL, Smout SA, Wall CSJ, et al. Exposure to Childhood Healthcare Discrimination and Healthcare Avoidance among Transgender and Gender Independent Adults during a Global Pandemic. Int J Environ Res Public Health 2022; 19.</a></li><li><a class="nounderline abstract_t">Vertigan AE, Harvey ES, Beyene T, et al. Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity. J Allergy Clin Immunol Pract 2023; 11:3107.</a></li><li><a class="nounderline abstract_t">Fleming LE, Kirkpatrick B, Backer LC, et al. Aerosolized red-tide toxins (brevetoxins) and asthma. Chest 2007; 131:187.</a></li><li><a class="nounderline abstract_t">Cheng YS, Zhou Y, Naar J, et al. Personal exposure to aerosolized red tide toxins (brevetoxins). J Occup Environ Hyg 2010; 7:326.</a></li><li><a class="nounderline abstract_t">Fleming LE, Bean JA, Kirkpatrick B, et al. Exposure and effect assessment of aerosolized red tide toxins (brevetoxins) and asthma. Environ Health Perspect 2009; 117:1095.</a></li><li><a class="nounderline abstract_t">Dreßler M, Friedrich T, Lasowski N, et al. Predictors and reproducibility of exercise-induced bronchoconstriction in cold air. BMC Pulm Med 2019; 19:94.</a></li><li><a class="nounderline abstract_t">Del Giacco SR, Firinu D, Bjermer L, Carlsen KH. Exercise and asthma: an overview. Eur Clin Respir J 2015; 2:27984.</a></li><li><a class="nounderline abstract_t">Gilbert IA, McFadden ER Jr. Airway cooling and rewarming. The second reaction sequence in exercise-induced asthma. J Clin Invest 1992; 90:699.</a></li><li><a class="nounderline abstract_t">Voelker R. Asthma forecast: why heat, humidity trigger symptoms. JAMA 2012; 308:20.</a></li><li><a class="nounderline abstract_t">Barne C, Alexis NE, Bernstein JA, et al. Climate change and our environment: the effect on respiratory and allergic disease. J Allergy Clin Immunol Pract 2013; 1:137.</a></li><li><a class="nounderline abstract_t">D'Amato G, Holgate ST, Pawankar R, et al. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. World Allergy Organ J 2015; 8:25.</a></li><li><a class="nounderline abstract_t">Cockcroft DW, Davis BE, Blais CM. Thunderstorm asthma: An allergen-induced early asthmatic response. Ann Allergy Asthma Immunol 2018; 120:120.</a></li><li><a class="nounderline abstract_t">Thien F, Davies JM, Hew M, et al. Thunderstorm asthma: an overview of mechanisms and management strategies. Expert Rev Clin Immunol 2020; 16:1005.</a></li><li><a class="nounderline abstract_t">Park JH, Lee E, Fechter-Leggett ED, et al. Associations of Emergency Department Visits for Asthma with Precipitation and Temperature on Thunderstorm Days: A Time-Series Analysis of Data from Louisiana, USA, 2010-2012. Environ Health Perspect 2022; 130:87003.</a></li><li><a class="nounderline abstract_t">Thien F, Beggs PJ, Csutoros D, et al. The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors. Lancet Planet Health 2018; 2:e255.</a></li><li><a class="nounderline abstract_t">D'Amato G, Annesi Maesano I, Molino A, et al. Thunderstorm-related asthma attacks. J Allergy Clin Immunol 2017; 139:1786.</a></li><li><a class="nounderline abstract_t">Douglass JA, Lodge C, Chan S, et al. Thunderstorm asthma in seasonal allergic rhinitis: The TAISAR study. J Allergy Clin Immunol 2022; 149:1607.</a></li><li><a class="nounderline abstract_t">Hughes DD, Mampage CBA, Jones LM, et al. Characterization of Atmospheric Pollen Fragments during Springtime Thunderstorms. Environ Sci Technol Letter 2020; 7:409.</a></li><li><a class="nounderline abstract_t">Chatelier J, Chan S, Tan JA, et al. Managing Exacerbations in Thunderstorm Asthma: Current Insights. J Inflamm Res 2021; 14:4537.</a></li><li><a class="nounderline abstract_t">Redmayne M. A proposed explanation for thunderstorm asthma and leukemia risk near high-voltage power lines: a supported hypothesis. Electromagn Biol Med 2018; 37:57.</a></li><li><a class="nounderline abstract_t">Hanstock HG, Ainegren M, Stenfors N. Exercise in Sub-zero Temperatures and Airway Health: Implications for Athletes With Special Focus on Heat-and-Moisture-Exchanging Breathing Devices. Front Sports Act Living 2020; 2:34.</a></li><li><a class="nounderline abstract_t">França-Pinto A, Mendes FA, de Carvalho-Pinto RM, et al. Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial. Thorax 2015; 70:732.</a></li><li><a class="nounderline abstract_t">Panagiotou M, Koulouris NG, Rovina N. Physical Activity: A Missing Link in Asthma Care. J Clin Med 2020; 9.</a></li><li><a class="nounderline abstract_t">de Lima FF, Pinheiro DHA, de Carvalho CRF. Physical training in adults with asthma: An integrative approach on strategies, mechanisms, and benefits. Front Rehabil Sci 2023; 4:1115352.</a></li><li><a class="nounderline abstract_t">Rao CK, Moore CG, Bleecker E, et al. Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program. Chest 2013; 143:984.</a></li><li><a class="nounderline abstract_t">Matteis M, Polverino F, Spaziano G, et al. Effects of sex hormones on bronchial reactivity during the menstrual cycle. BMC Pulm Med 2014; 14:108.</a></li><li><a class="nounderline abstract_t">Brenner BE, Holmes TM, Mazal B, Camargo CA Jr. Relation between phase of the menstrual cycle and asthma presentations in the emergency department. Thorax 2005; 60:806.</a></li><li><a class="nounderline abstract_t">Graziottin A, Serafini A. Perimenstrual asthma: from pathophysiology to treatment strategies. Multidiscip Respir Med 2016; 11:30.</a></li><li><a class="nounderline abstract_t">Semik-Orzech A, Skoczyński S, Pierzchała W. Serum estradiol concentration, estradiol-to-progesterone ratio and sputum IL-5 and IL-8 concentrations are increased in luteal phase of the menstrual cycle in perimenstrual asthma patients. Eur Ann Allergy Clin Immunol 2017; 49:161.</a></li><li><a class="nounderline abstract_t">Skoczynski S, Semik-Orzech A, Sozanska E, et al. Bronchial hyperreactivity in perimenstrual asthma is associated with increased Th-2 response in lower airways. J Thorac Dis 2017; 9:2015.</a></li><li><a class="nounderline abstract_t">Martinez-Moragón E, Plaza V, Serrano J, et al. Near-fatal asthma related to menstruation. J Allergy Clin Immunol 2004; 113:242.</a></li><li><a class="nounderline abstract_t">Pasaoglu G, Mungan D, Abadoglu O, Misirligil Z. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma? J Asthma 2008; 45:95.</a></li><li><a class="nounderline abstract_t">Morales DR, Dreischulte T, Lipworth BJ, et al. Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol 2016; 82:814.</a></li><li><a class="nounderline abstract_t">Kaiserman I, Fendyur A, Vinker S. Topical beta blockers in asthmatic patients-is it safe? Curr Eye Res 2009; 34:517.</a></li><li><a class="nounderline abstract_t">Hepsen IF, Yildirim Z, Yilmaz H, Kotuk M. Preventive effect of lacrimal occlusion on topical timolol-induced bronchoconstriction in asthmatics. Clin Exp Ophthalmol 2004; 32:597.</a></li><li><a class="nounderline abstract_t">Nelson HS. Prospects for antihistamines in the treatment of asthma. J Allergy Clin Immunol 2003; 112:S96.</a></li><li><a class="nounderline abstract_t">Apter AJ, Garcia LA, Boyd RC, et al. Exposure to community violence is associated with asthma hospitalizations and emergency department visits. J Allergy Clin Immunol 2010; 126:552.</a></li><li><a class="nounderline abstract_t">Rosas-Salazar C, Han YY, Brehm JM, et al. Gun Violence, African Ancestry, and Asthma: A Case-Control Study in Puerto Rican Children. Chest 2016; 149:1436.</a></li><li><a class="nounderline abstract_t">Kew KM, Nashed M, Dulay V, Yorke J. Cognitive behavioural therapy (CBT) for adults and adolescents with asthma. Cochrane Database Syst Rev 2016; 9:CD011818.</a></li><li><a class="nounderline abstract_t">Wright RJ, Cohen S, Carey V, et al. Parental stress as a predictor of wheezing in infancy: a prospective birth-cohort study. Am J Respir Crit Care Med 2002; 165:358.</a></li><li><a class="nounderline abstract_t">Ramratnam SK, Visness CM, Jaffee KF, et al. Relationships among Maternal Stress and Depression, Type 2 Responses, and Recurrent Wheezing at Age 3 Years in Low-Income Urban Families. Am J Respir Crit Care Med 2017; 195:674.</a></li><li><a class="nounderline abstract_t">Yorke J, Fleming S, Shuldham C, et al. Nonpharmacological interventions aimed at modifying health and behavioural outcomes for adults with asthma: a critical review. Clin Exp Allergy 2015; 45:1750.</a></li></ol></div><div id="topicVersionRevision">Topic 562 Version 56.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33280709" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33280709" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32627764" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Causes and Phenotypes of Work-Related Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28667069" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Role of human metapneumovirus and respiratory syncytial virus in asthma exacerbations: where are we now?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020463" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The role of human rhinovirus (HRV) species on asthma exacerbation severity in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27796793" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Immune Responses in Rhinovirus-Induced Asthma Exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28689842" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33632765" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Neutrophils in asthma: the good, the bad and the bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25229000" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28982576" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Asthma predisposition and respiratory syncytial virus infection modulate transient receptor potential vanilloid 1 function in children's airways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28187208" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26044772" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Infection with Rhinovirus Facilitates Allergen Penetration Across a Respiratory Epithelial Cell Layer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16522453" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The September epidemic of asthma hospitalization: school children as disease vectors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26858436" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28238748" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21410369" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26518090" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28608756" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26586037" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29756701" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prevalence of Mycoplasma pneumoniae infection in pediatric patients with acute asthma exacerbation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28634021" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mycoplasma pneumoniae and health outcomes in children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11794219" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The safety of inactivated influenza vaccine in adults and children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23450529" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Vaccines for preventing influenza in people with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27270612" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pneumonia in Children Presenting to the Emergency Department With an Asthma Exacerbation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27177430" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24915164" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Fungal exposure, atopy, and asthma exacerbations in Puerto Rican children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25159468" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28502823" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36961370" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29964057" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Alternaria is associated with asthma symptoms and exhaled NO among NYC children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11242600" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Environmental allergen avoidance: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24834193" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Adverse reactions to the sulphite additives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18812366" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effects of improved home heating on asthma in community dwelling children: randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15333849" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Association of domestic exposure to volatile organic compounds with asthma in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20656941" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Desert dust exposure is associated with increased risk of asthma hospitalization in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27115265" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Association of Changes in Air Quality With Bronchitic Symptoms in Children in California, 1993-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27965778" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The management of asthmatic smokers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32094459" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Acute associations between PM2.5 and ozone concentrations and asthma exacerbations among patients with and without allergic comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36608946" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15790982" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28214106" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33498608" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The Impact of Tobacco Smoking on Adult Asthma Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24021528" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Impact of environmental tobacco smoke on children with asthma, United States, 2003-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24021528" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Impact of environmental tobacco smoke on children with asthma, United States, 2003-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24021528" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Impact of environmental tobacco smoke on children with asthma, United States, 2003-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16645173" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29883409" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36978106" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29452260" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The highs and lows of marijuana use in allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25837035" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effects of quitting cannabis on respiratory symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15075170" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Randomized controlled trial of unflued gas heater replacement on respiratory health of asthmatic schoolchildren.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25726560" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Volatile organic compounds and risk of asthma and allergy: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26748224" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Volatile organic compounds and particulate matter in child care facilities in the District of Columbia: Results from a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28102830" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Can exhaled volatile organic compounds predict asthma exacerbations in children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15054004" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Asthma, wheezing, and allergies in Russian schoolchildren in relation to new surface materials in the home.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24329990" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Levels and sources of volatile organic compounds in homes of children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33396261" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Reported Neighborhood Traffic and the Odds of Asthma/Asthma-Like Symptoms: A Cross-Sectional Analysis of a Multi-Racial Cohort of Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28319180" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32867076" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Impact of Air Pollution on Asthma Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32867076" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Impact of Air Pollution on Asthma Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37733685" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Canadian Wildfire Smoke and Asthma Syndrome Emergency Department Visits in New York City.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32162689" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Unprecedented smoke-related health burden associated with the 2019-20 bushfires in eastern Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35742688" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Exposure to Childhood Healthcare Discrimination and Healthcare Avoidance among Transgender and Gender Independent Adults during a Global Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37329954" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17218574" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Aerosolized red-tide toxins (brevetoxins) and asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20379895" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Personal exposure to aerosolized red tide toxins (brevetoxins).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19654919" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Exposure and effect assessment of aerosolized red tide toxins (brevetoxins) and asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31097027" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Predictors and reproducibility of exercise-induced bronchoconstriction in cold air.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26672959" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Exercise and asthma: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1522227" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Airway cooling and rewarming. The second reaction sequence in exercise-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22760272" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Asthma forecast: why heat, humidity trigger symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23687635" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Climate change and our environment: the effect on respiratory and allergic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26207160" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29413334" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Thunderstorm asthma: An allergen-induced early asthmatic response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32960102" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Thunderstorm asthma: an overview of mechanisms and management strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35921071" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Associations of Emergency Department Visits for Asthma with Precipitation and Temperature on Thunderstorm Days: A Time-Series Analysis of Data from Louisiana, USA, 2010-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29880157" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28342913" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Thunderstorm-related asthma attacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34774618" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Thunderstorm asthma in seasonal allergic rhinitis: The TAISAR study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Characterization of Atmospheric Pollen Fragments during Springtime Thunderstorms</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34526800" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Managing Exacerbations in Thunderstorm Asthma: Current Insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29708457" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A proposed explanation for thunderstorm asthma and leukemia risk near high-voltage power lines: a supported hypothesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33345026" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Exercise in Sub-zero Temperatures and Airway Health: Implications for Athletes With Special Focus on Heat-and-Moisture-Exchanging Breathing Devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26063507" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32150999" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Physical Activity: A Missing Link in Asthma Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36873818" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Physical training in adults with asthma: An integrative approach on strategies, mechanisms, and benefits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23632943" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24984749" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Effects of sex hormones on bronchial reactivity during the menstrual cycle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16192365" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Relation between phase of the menstrual cycle and asthma presentations in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27482380" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Perimenstrual asthma: from pathophysiology to treatment strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28752719" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Serum estradiol concentration, estradiol-to-progesterone ratio and sputum IL-5 and IL-8 concentrations are increased in luteal phase of the menstrual cycle in perimenstrual asthma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28840001" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Bronchial hyperreactivity in perimenstrual asthma is associated with increased Th-2 response in lower airways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14767436" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Near-fatal asthma related to menstruation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18350399" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27161880" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19899964" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Topical beta blockers in asthmatic patients-is it safe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575830" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Preventive effect of lacrimal occlusion on topical timolol-induced bronchoconstriction in asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530795" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Prospects for antihistamines in the treatment of asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20816190" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Exposure to community violence is associated with asthma hospitalizations and emergency department visits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26905363" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Gun Violence, African Ancestry, and Asthma: A Case-Control Study in Puerto Rican Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27649894" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Cognitive behavioural therapy (CBT) for adults and adolescents with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11818321" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Parental stress as a predictor of wheezing in infancy: a prospective birth-cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27654103" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Relationships among Maternal Stress and Depression, Type 2 Responses, and Recurrent Wheezing at Age 3 Years in Low-Income Urban Families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25675860" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Nonpharmacological interventions aimed at modifying health and behavioural outcomes for adults with asthma: a critical review.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
